Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical efficacy, PK/PD, and variability of insulin glargine U300 vs U100 in type 1 diabetes
2015-002135-17Phase 3Completed
- Sponsor
- University of Perugia
- Start
- Dec 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of insulin glargine in diabetes mellitus type 1 (T1D) (2 arms), sponsored by University of Perugia. Primary endpoint: Pre-dinner plasma glucose non-inferiority. Started Dec 2020; status: completed.
02
Drugs
insulin glargine
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2015-002135-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002135-17.